And of course not every patient is a perfect candidate for stem cell or the condition can be handled in an identical fashion. That is one of the primary messages you must take away from responsibly conducted regenerative medicine.
For all most patients looking for stem cell treatment in Thailand, cost (cell dose & timing) is normally the first question to be asked. These are key but not the starting point. What the first question should be: Is this patient treatable, and what entails a reasonable target?
Reger et al, have concluded that stem cell therapy may be better understood as a biological support modality with stem cell therapy exerting effects through their amphiphilic nature which attracts proteins and monocytes. They are mainly investigated for their paracrine functions due to properties of releasing signaling molecules capable, in part, to modulate inflammation balance, immune regulation and tissue repair communication pathways. They are not miracle cells and should never be misrepresented as a cure all.
Why Patient Selection Is Important
Not every patient with an indication for regenerative medicine should be accepted into a good program automatically. How the body responds depends on several factors, including age and disease stage & degree of inflammation as well as blood flow/reserve capacity, metabolic health/stress status/lifestyle/rehab engagement.
This means two patients with an identical diagnosis might respond to treatment differently. A case with moderate knee arthrosis and preserved joint space may be a better candidate than other patient who presented total bone on the surface contact in position of full compression. Someone with a recent nerve irritant may respond entirely differently than long-standing severe damage to the nerves. If diabetes is poorly controlled and there are also circulation problems, a patient will not be as much of an optimal treatment candidate as one whose blood sugar control is better.
This is because stem cell therapy acts from inside the biological environment of its patient. But if the that environment is too fragile, threatened or undeveloped then the action may be sub-standard.
Stem cell therapy designed based on the usage of certain drugs because they can target specific population.
It is usually patients with mild to moderate degenerative or inflammatory diseases, where there remains significant functional tissue.
For orthopedic conditions, these may include patients with mild to moderate knee osteoarthritis, early or 1st stage disc degeneration and other chronic joint problems including tendon damage (Tendinopathy & Tendinosis), following operative ligament rehabilitation or some experienced but failed conservative care without having progressed onto ideal operable status.
In the case of systemic or inflammatory conditions, patients can be considered if there is a strong medical rationale i.e. one in which immune imbalance exists (e.g., elevated IgG), symptoms indicate chronic inflammation (high C-reactive protein levels) and/or evidence that tissues are under stress from recovery support needs. Treatment planning in these instances has to be medically supervised and to focus on individualization.
Patients who are active participants in recovery often make the best candidates for guild. You are also trained on, through rehabilitation: sleep; weight loss; blood sugar control alcohol cessation; healthy nutrition and follow-up visits.
This does not mean that stem cell therapy is a full passive treatment. This, the cells supply augmentative biological signals but your body needs to environment in which you provide appropriate response due right conditions.
Who Should Be More Careful?
There are patients who need to take extra precautions when it comes to stem cell therapy.
May not benefit if advanced structural damage exists. In fact, patients may be disappointed that severe degenerative conditions from longstanding joint destruction such as bone-on-bone arthritis, advanced organ dysfunction or major spinal instability with neural impact do not respond the way they would like. In these examples, stem cell therapy might be advocated as supportive care but not because it is a substitute for needed surgery or accepted treatment options.
For example, patients with active infection; uncontrolled cancer; unstable heart disease (e.g. New York Heart Association class ≥ III); severe uncontrolled autoimmune activity; major blood disorders or poorly controlled diabetes may require additional medical review prior to regenerative treatment being administered.
Similarly, patients who take other very strong immune-suppressing medications or blood thinners may also need some planning. Not only the cells themselves but also procedures like IV infusion, joint injection, intrathecal injection or even intraspinal disc injections are a worry.
For confirming a protocol, any responsible clinic must collect patients medical history including current medications (If Any), blood tests and imaging reports after proper diagnosis, allergies due to which type of wristwatch at no point in time is better experience as opposed to it.
The Role of Expectations
Selection of patient is also a matter of expectation
An ideal candidate realizes that stem cell treatment is not a wonder cure. And this objective may be anything — lower inflammation, increased comfort of moving about, better mobility control and progressive slow down; more help during recovery or improved quality-of-life. These are different goals than promising reversal of disease.
Anyone expecting to see immediate results instantly or anyone promising guaranteed results may need a preliminary education prior to treatment. It is always slow walking in regenerative medicine, but the results could be condition specific and also vary with cell quality (tissue manufacturer), route of administration, rehabilitation or ‘basic health’.
What Should a Responsible Clinic Do?
Why You May or May Not Be A Responsible Clinic Should Explain It There should be a treatment plan drafted based on your medical evaluation, rather than just tossing together an established package.
Patients should clearly understand the source of cells, donor screening, laboratory standards (cell viability dose and treatment route), potential hazards involved in treatments performed either clinically or preclinically conducted, anticipated time course, follow-up required post-treatment.
Never the Program that Promises the Most They are the ones that understand and distill science, acknowledge limits, than most importantly design treatment around what is truly wrong with the patient.
Final Thoughts
Patient Selection for Stem Cell Therapy It is a standard for safety and quality. The right patient, with the right disease stage and at the right time along their treatment plan may have a greater likelihood of meaningful response. Inevitably, risk to the wrong patient or in my opinion at least a false sense of expectation and disappointment will ensure.
If you are a patient considering stem cell therapy in Thailand, your first step does not involve picking the largest dose or lowest price. It is selecting a medically responsible staff to honestly answer one main question: Is stem cell therapy appropriate for this patient, at this stage, for this goal?